Award

Ask AI about this notice

Summarise, research or assess it with AI

View Markdown

Share this notice

Send this contract to a colleague

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care

The NHS Commissioning Board (operating under the name of NHS England)

This public procurement record has 2 releases in its history.

Award

08 Sep 2021 at 15:50

Award Notice
Tender

27 Apr 2021 at 13:03

Tender Notice
Summary of the contracting process

The NHS Commissioning Board (operating under the name of NHS England) has initiated a framework agreement for the supply of Adult Influenza Vaccines for Secondary Care, which commenced on 1 September 2021 and is set to run for a period of 12 months, with options for extensions up to a total maximum of 48 months. This procurement, classified under the CPV code 33651660, pertains to the goods category specifically targeting the healthcare industry. Key deadlines include the tendering period, which closed on 2 June 2021, with the award likely following the bid opening date on the same day in Runcorn, UK.

This opportunity presents significant growth potential for businesses within the pharmaceutical and healthcare sectors, particularly manufacturers and suppliers of vaccines. Companies that excel in quality assurance, supply chain management, and offer competitive pricing are well-suited to compete for this contract. Moreover, participation in this framework can enable businesses to establish long-term relationships with NHS entities and contribute to public health initiatives, fostering both profitability and social responsibility.

How relevant is this notice?

Notice Information

Notice Title

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care

Notice Description

NHS Framework Agreement for the supply of Adult Influenza Vaccines - Secondary Care. Period of framework agreement: 1 September 2021 to 31 August 2022 with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 36 months. Total maximum framework agreement including extension options will be no more than 48 months . Please refer to the invitation to offer documents for a list of the purchasing points.

Lot Information

Lot 1 - aQIV

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 2 - QIV-HD

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 3 - QIVc

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Renewal: The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 4 - QIVr

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods upto36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Lot 5 - QIVe

NHS Framework Agreement for the supply of Adult Influenza Vaccines for Secondary Care. The framework will commence on 1 September 2021 for a period of 12 months, with an option or options to extend (at the Authority's discretion) for a period or periods up to 36 months. Total maximum framework agreement including extension options will be no more than 48 months. Please refer to the offer documents for the list of purchasing points

Options: option or options to extend (at the Authority's discretion) for a period or periods up to36 months. Total maximum framework agreement including extension options will be no more than 48 months.

Notice Details

Publication & Lifecycle

Open Contracting ID
ocds-h6vhtk-02aa9d
Publication Source
Find A Tender Service
Latest Notice
https://www.find-tender.service.gov.uk/Notice/022304-2021
Current Stage
Award
All Stages
Tender, Award

Procurement Classification

Notice Type
Tender Notice
Procurement Type
Framework
Procurement Category
Goods
Procurement Method
Open
Procurement Method Details
Open procedure
Tender Suitability
Not specified
Awardee Scale
Large

Common Procurement Vocabulary (CPV)

CPV Divisions

33 - Medical equipments, pharmaceuticals and personal care products

CPV Codes

33651660 - Influenza vaccines

Notice Value(s)

Tender Value
£29,200,000 £10M-£100M
Lots Value
Not specified
Awards Value
Not specified
Contracts Value
Not specified

Notice Dates

Publication Date
8 Sep 20214 years ago
Submission Deadline
2 Jun 2021Expired
Future Notice Date
Not specified
Award Date
18 Aug 20215 years ago
Contract Period
1 Sep 2021 - 31 Aug 2022 6-12 months
Recurrence
Not specified

Notice Status

Tender Status
Complete
Lots Status
Cancelled
Awards Status
Active, Unsuccessful
Contracts Status
Active

Buyer & Supplier

Contracting Authority (Buyer)

Main Buyer
The NHS Commissioning Board (operating under the name of NHS England)
Contact Name
Available with D3 Tenders Premium →
Contact Email
Available with D3 Tenders Premium →
Contact Phone
Available with D3 Tenders Premium →

Buyer Location

Locality
RUNCORN
Postcode
WA7 2ES
Postcode Area
Warrington
Country
England
Major Region (ITL 1)
TLD North West (England)
Basic Region (ITL 2)
TLD7 Merseyside
Small Region (ITL 3)
TLD71 East Merseyside
Delivery Location
Not specified
Local Authority
Halton
Electoral Ward
Halton Lea
Westminster Constituency
Runcorn and Helsby

Supplier Information

Number of Suppliers
2
Supplier Names

Aventis Pharma ltd t/a Sanofi

Seqirus UK Limited

Further Information

Open Contracting Data Standard (OCDS)

View full OCDS Record for this contracting process

JSON Markdown

The Open Contracting Data Standard (OCDS) is a framework designed to increase transparency and access to public procurement data in the public sector. It is widely used by governments and organisations worldwide to report on procurement processes and contracts.

Loading OCDS record...